Skip to content
MedsAcross

Brand family

Auvelity

United States
Presentations
3
Markets
1

Auvelity is a brand of Bupropion and Dextromethorphan and Dextromethorphan marketed by Axsome Therapeutics, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Bupropion and Dextromethorphan, Dextromethorphan
Brand owner
Axsome Therapeutics
Registered in
United States
Strengths and forms
105 mg/30 mg extended-release tablet, 105 mg/45 mg extended-release tablet, kit

All presentations

MedicineManufacturerRegisterAvailability
Auvelity 105 mg/30 mg extended-release tabletOralAxsome TherapeuticsUS FDAAvailable on request
Auvelity 105 mg/45 mg extended-release tabletOralAxsome TherapeuticsUS FDAAvailable on request
Auvelity kitAxsome TherapeuticsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Auvelity

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.